Zenas BioPharma (ZBIO) Short Interest
Nasdaq • ZBIO • US98937L1052
As of Oct 28, 2026, ORTEX estimated 24.6% of free float sold short, 20.5 days to cover, cost to borrow 0.78%. Sign up for live short interest data.
Nasdaq • ZBIO • US98937L1052
As of Oct 28, 2026, ORTEX estimated 24.6% of free float sold short, 20.5 days to cover, cost to borrow 0.78%. Sign up for live short interest data.
This page tracks how heavily Zenas BioPharma (Nasdaq:ZBIO) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Zenas BioPharma (Nasdaq: ZBIO) has a market capitalization of $1.95B. Last close $28.70 (as of 2026-11-12); 52-week range $13.50 to $44.60. ORTEX data as of 2026-10-28: short interest was 24.58% of free float, 20.5 days to cover and the average cost to borrow was 0.78%. Sign up for live short interest data.